Objective
Phage display is a relatively new technique which involves the expression of peptides or proteins on the surface of phage as fusion proteins attached to normal phage proteins. The coupling of a protein on the surface of a phage with the gene which encodes it within the phage allows a rapid evolution of protein properties on the basis of their binding or (in some cases) catalytic activity, by a series of recursive cycles of phage binding, elution and amplification. This technique started with the exposition of peptides, used initially to identify monoclonal antibody epitopes and subsequently the binding sites recognized by other proteins, and has since progressed to include the exposition of a large number of known proteins. One of the most successful applications of phage display has been the relatively easy derivation of monoclonal antibodies against many diverse antigens using large phage antibody libraries, and the subsequent improvement of the affinity of selected antibodies by their mutation and further selection. The improvement of the binding affinity of hormones to their receptors (e.g. growth hormone) have also been carried out using phage display. Following the display of variants of known proteins, elegant methods have now been developed to produce cDNA libraries displayed on phage where selection of unknown proteins can be made on the basis of their binding properties.
Most methods used for selection have usually been physical in nature. However, recent developments have attempted to exploit the biology of the phage by coupling selection with infection, a selection method which is likely to be very powerful if it can be fully developed.
The importance of phage display as a new industrial tool is demonstrated by the large number of American (and latterly European, some included here) biotechnology companies which are now using this technique to provide either leads in the development of new drugs, or to create new protein based drugs based on antibodies or peptides.
The objectives of this large concerted action are to bring together most of the groups in Europe actively using, or developing improved, phage display methods. By regular meetings and lab visits it is expected that reagents will be exchanged and exciting developments in this field will be rapidly communicated to the European 'phage display community', so providing a collective benefit and competitive advantage. Specific research objectives can be grouped into the following areas:
A. Improvements in the quality of antibodies selected using phage display by increasing the size and quality of the libraries, by improving the antibody frameworks so that they are better expressed on phage, and by developing mutati and selection methods which improve the affinity of phage antibodies once initial binders have been selected.
B. The improvement of selection methods, including the development of biological methods of selection ('selection by infection') and the development of selection methods which permit the isolation of phage antibodies specific for a particular diseased or physiologically altered tissue.
C. The use of phage display to select specific antibodies or peptides which recognise proteins of medical or commercial interest.
D. Improvement of vectors used in phage display.
E. The further development of techniques which permit the cloning of cDNA on phage.
F. The development of novel applications of peptide phage libraries by the creation of libraries which are either modified (by e.g. phosphorylation) or constrained, or by the isolation of peptide phage which are specific for particular diseases.
G. The use of phage display to alter the properties of proteins of medical or commercial interest.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences microbiology virology
- natural sciences biological sciences biochemistry biomolecules proteins
- natural sciences biological sciences genetics mutation
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
34013 Trieste
Italy
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.